Seres Therapeutics (MCRB) Q3 2026 Earnings

5AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-2.49
-1.35
-0.2
0.94

Details

Expected EPS
-2.185
Actual EPS
N/A
Surprise EPS
2.19
Surprise Percent
+100%

Description

Seres Therapeutics (MCRB) will report earnings of for Q3 2026 on August 05, 2026.

0 Comments

Share your thoughts